BSX Operating Cash Flow (Statement)

Boston Scientific · Operating Cash Flow (Statement)

BSX logo

BSX Operating Cash Flow (Statement)

Latest reported$4.53B
BSX TTM Cash from Operations ($42.50M → $4.53B)
High-resolution chart · PNG

BSX operating cash flow (statement) history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Boston Scientific Operating Cash Flow (Statement) — Trailing twelve months (TTM) (USD)
Period endingOperating Cash Flow (Statement) (USD)
4,529,000,000
4,341,000,000
4,534,000,000
4,626,000,000
4,285,000,000
3,812,000,000
3,435,000,000
2,936,000,000
2,632,000,000
2,477,000,000
2,503,000,000
2,353,000,000
2,126,000,000
1,774,000,000
1,526,000,000
1,197,000,000
1,191,000,000
1,528,000,000
1,870,000,000
2,065,000,000
2,243,000,000
1,869,000,000
1,508,000,000
1,527,000,000
1,386,000,000
1,409,000,000
1,836,000,000
1,163,000,000
1,162,000,000
467,000,000
310,000,000
1,163,000,000
1,114,000,000
1,814,000,000
1,614,000,000
1,208,000,000
725,000,000
849,000,000
972,000,000
835,000,000
1,274,000,000
913,000,000
600,000,000
711,000,000
649,000,000
874,000,000
1,269,000,000
1,102,000,000
1,007,000,000
1,119,000,000
1,108,000,000
1,204,000,000
1,225,000,000
1,235,000,000
1,260,000,000
1,240,000,000
1,334,000,000
1,317,000,000
1,008,000,000
1,108,000,000
616,000,000
512,000,000
325,000,000
-453,000,000
157,000,000
290,000,000
835,000,000
1,218,000,000
1,372,000,000
1,211,000,000
1,216,000,000
1,470,000,000
1,306,000,000
1,259,000,000
934,000,000
991,000,000
998,000,000
1,222,000,000
1,845,000,000
1,990,000,000
1,222,000,000
1,026,000,000
903,000,000
1,050,000,000
1,910,000,000
2,203,000,000
1,804,000,000
1,381,000,000
1,007,000,000
720,000,000
787,000,000
749,000,000
872,000,000
786,000,000
736,000,000
702,000,000
494,000,000
458,000,000
490,000,000
505,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.